Zura Bio Limited
ZURAHealthcare|Biotechnology|US
$4.09
+0.37 (+9.95%)
DCF Value
$1.15
Tangible Book / Share
$1.39
Cash / Share
$1.47
About
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
Stock Price
+17.5%(1Y)
1M
-1.0%
3M
-31.5%
6M
-14.6%
YTD
-21.9%
1Y
+4.6%
3Y
-7.7%
5Y
-43.5%
Pipeline Summary
0 total trials0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
Key Facts
Market Cap$394.0M
Employees40 (+33% YoY)
CEOSandeep C. Kulkarni
IPO DateMar 21, 2023
Beta-0.04
52-Week Range$3.25 – $7.44
Avg Volume2,244,093
ExchangeNASDAQ
Websitezurabio.com
Ownership
Float47.3%
Shares Outstanding96.3M
Recent Insider Trades
Mathew Marlyn TeresaOTHER
Apr 17, 20260 shares
Mathew Marlyn TeresaOTHER
Apr 17, 202611,133 shares
Mathew Marlyn TeresaOTHER
Apr 17, 202690,000 shares @ $3.38
Mathew Marlyn TeresaOTHER
Apr 17, 202681,150 shares @ $1.20
Mathew Marlyn TeresaOTHER
Apr 17, 202666,220 shares @ $6.03
Peers
AARDAardvark Therapeutics, Inc. Common Stock
$25.6MARCTArcturus Therapeutics Holdings Inc.
$294.2MASMBAssembly Biosciences, Inc.
$415.8MENTAEnanta Pharmaceuticals, Inc.
$320.4MFHTXFoghorn Therapeutics Inc.
$111.1MIMRXImmuneering Corporation
$238.3MNAUTNautilus Biotechnolgy, Inc.
$284.0MPYXSPyxis Oncology, Inc.
$105.2MRecent News
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 27, 2026 · businesswire.com
Zura Bio Reports Third Quarter 2026 Financial Results and Recent Corporate Updates
Oct 27, 2026 · gurufocus.com
Zura Bio Reports Third Quarter 2026 Financial Results and Recent Corporate Updates
Oct 27, 2026 · businesswire.com
Zura Bio to Participate in the Cantor Global Healthcare Conference
Aug 31, 2026 · businesswire.com
Contrasting Zura Bio (NASDAQ:ZURA) and Soligenix (NASDAQ:SNGX)
Aug 27, 2026 · defenseworld.net
Data last updated: Nov 9, 2026, 04:41 AM